Original Articles
Visualizações

Arq. Bras. Oftalmol. 2022; 85 (2): 10.5935/0004-2749.20220017

Total: 2931

Tear Lysozyme in Sjögren´s syndrome, Meibomian gland dysfunction, and non-dry-eye

Martín Berra1; Gustavo Galperín1; Federico Berra2; Maria Isabel Marquez2; Mariana Mandaradoni3; Julia Tau4; Alejandro Berra4

DOI: 10.5935/0004-2749.20220017

1. Hospital Oftalmológico “Pedro Lagleyze”, Buenos Aires, Argentina
2. Bioquímica Ocular, Buenos Aires, Argentina
3. Hospital Posadas Buenos Aires, Argentina
4. Laboratorio Traslacional de Inmunopatologia & Oftalmologia, Departamento de Patologia, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina

Corresponding author

Martín Berra
E-mail: [email protected]

Funding: This study received no specific financial support

Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose


Print PDF English
Open Access
Share

How to cite this article:

Berra M, Galperín G, Berra F, Marquez MI, Mandaradoni M, Tau J, et al. Lisozima lacrimal na síndrome de Sjögren, disfunção da glândula meibomiana e olho não seco. Arq. Bras. Oftalmol. 2022;85(2):. 10.5935/0004-2749.20220017
Export citation